ArticleThe Journal of clinical investigation2026

Reversing enhancer RNA-mediated IKBKE gene repression enables synthetic anticancer immunity in prostate cancer models.

Xiang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.